RACHAEL TRAHAN: Open Payments
NPI 1891223459 · YOUNGSVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 51 payments from 13 companies in 2025. Trend: 2023 $531 · 2024 $674 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $391 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Lilly USA, LLC | 2 | $45 |
| PFIZER INC. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
Products named: VRAYLAR, UBRELVY, CAPLYTA, QULIPTA, AIRSUPRA, JARDIANCE, NURTEC ODT, CREON.
Industry payments across LA — which companies pay providers there.
